Man Group PLC Novo Cure LTD Transaction History

Man Group PLC

  • $36 Billion
  • Q3 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$11.83 - $24.05 $2.88 Million - $5.86 Million
-243,653 Reduced 44.8%
300,171 $5.14 Million
Q1 2024

May 15, 2024
BUY
$12.42 - $17.29 $4.8 Million - $6.68 Million
386,436 Added 245.53%
543,824 $8.5 Million
Q4 2023

Feb 14, 2024
BUY
$11.13 - $15.78 $120,437 - $170,755
10,821 Added 7.38%
157,388 $2.35 Million
Q3 2023

Nov 14, 2023
BUY
$16.15 - $42.35 $754,366 - $1.98 Million
46,710 Added 46.78%
146,567 $2.37 Million
Q2 2023

Aug 14, 2023
BUY
$40.29 - $82.51 $1.23 Million - $2.51 Million
30,466 Added 43.9%
99,857 $4.14 Million
Q1 2023

May 15, 2023
BUY
$56.44 - $118.81 $3.92 Million - $8.24 Million
69,391 New
69,391 $4.17 Million
Q3 2022

Nov 14, 2022
BUY
$67.99 - $89.57 $203,290 - $267,814
2,990 New
2,990 $227,000
Q2 2022

Aug 15, 2022
SELL
$56.6 - $89.9 $2.02 Million - $3.21 Million
-35,722 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$60.15 - $84.52 $2.97 Million - $4.18 Million
-49,448 Reduced 58.06%
35,722 $2.96 Million
Q4 2021

Feb 14, 2022
SELL
$75.08 - $121.99 $218,933 - $355,722
-2,916 Reduced 3.31%
85,170 $6.4 Million
Q3 2021

Nov 15, 2021
BUY
$116.17 - $194.55 $5.31 Million - $8.9 Million
45,727 Added 107.95%
88,086 $10.2 Million
Q2 2021

Aug 16, 2021
BUY
$130.4 - $225.58 $140,440 - $242,949
1,077 Added 2.61%
42,359 $9.4 Million
Q1 2021

May 17, 2021
BUY
$124.11 - $190.17 $530,570 - $812,976
4,275 Added 11.55%
41,282 $5.46 Million
Q4 2020

Feb 16, 2021
SELL
$112.16 - $174.14 $3.62 Million - $5.62 Million
-32,282 Reduced 46.59%
37,007 $6.4 Million
Q3 2020

Nov 16, 2020
BUY
$58.05 - $111.31 $604,590 - $1.16 Million
10,415 Added 17.69%
69,289 $7.71 Million
Q2 2020

Aug 14, 2020
BUY
$57.2 - $74.41 $1.91 Million - $2.49 Million
33,437 Added 131.45%
58,874 $3.49 Million
Q1 2020

May 15, 2020
SELL
$57.05 - $95.75 $624,640 - $1.05 Million
-10,949 Reduced 30.09%
25,437 $1.71 Million
Q4 2019

Feb 18, 2020
BUY
$68.3 - $93.8 $1.78 Million - $2.45 Million
26,086 Added 253.26%
36,386 $3.07 Million
Q3 2019

Nov 14, 2019
SELL
$61.86 - $97.8 $2.12 Million - $3.35 Million
-34,226 Reduced 76.87%
10,300 $770,000
Q2 2019

Aug 14, 2019
BUY
$42.22 - $63.23 $1.54 Million - $2.31 Million
36,533 Added 457.06%
44,526 $2.82 Million
Q1 2019

May 15, 2019
SELL
$31.96 - $56.12 $191,472 - $336,214
-5,991 Reduced 42.84%
7,993 $385,000
Q4 2018

Feb 14, 2019
SELL
$28.72 - $52.63 $4.5 Million - $8.25 Million
-156,772 Reduced 91.81%
13,984 $468,000
Q3 2018

Nov 14, 2018
BUY
$32.0 - $52.4 $724,192 - $1.19 Million
22,631 Added 15.28%
170,756 $8.95 Million
Q2 2018

Aug 14, 2018
BUY
$19.85 - $32.0 $123,228 - $198,656
6,208 Added 4.37%
148,125 $4.64 Million
Q1 2018

May 15, 2018
BUY
$19.3 - $23.65 $2.74 Million - $3.36 Million
141,917 New
141,917 $3.09 Million

Others Institutions Holding NVCR

# of Institutions
263
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email